Scarica l'app Stockscreener
1.53
3.16%
-0.05
Dopo l'orario di chiusura:
1.53
Precedente Chiudi:
$1.58
Aprire:
$1.57
Volume 24 ore:
204.25K
Relative Volume:
0.50
Capitalizzazione di mercato:
$40.68M
Reddito:
$155.00K
Utile/perdita netta:
$-30.01M
Rapporto P/E:
-0.9162
EPS:
-1.67
Flusso di cassa netto:
$-11.98M
1 W Prestazione:
-1.92%
1M Prestazione:
-25.00%
6M Prestazione:
-33.48%
1 anno Prestazione:
-71.13%
Intervallo 1D:
$1.50
$1.57
Intervallo di 1 settimana:
$1.47
$1.655
Portata 52W:
$1.38
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Nome
Inmune Bio Inc
Settore
Industria
Telefono
(858) 964-3720
Indirizzo
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Confronta INMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.53 | 42.00M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-01 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-21 | Iniziato | Alliance Global Partners | Buy |
| 2024-09-27 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Scotiabank | Sector Outperform |
| 2023-06-01 | Iniziato | Robert W. Baird | Outperform |
| 2022-05-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-21 | Iniziato | B. Riley Securities | Buy |
| 2021-01-22 | Reiterato | Maxim Group | Buy |
| 2020-09-01 | Iniziato | BTIG Research | Buy |
| 2020-07-15 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Inmune Bio Inc Borsa (INMB) Ultime notizie
Energy Moves: Can INmune Bio Inc. stock deliver sustainable ROEMarket Risk Summary & Free Safe Capital Growth Stock Tips - ulpravda.ru
Will INmune Bio Inc. stock outperform Dow Jones indexJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Is INmune Bio Inc. stock vulnerable to regulatory risksReal-Time Stock Alerts & Boost Wealth With Growth - ulpravda.ru
Aug EndMonth: Will INmune Bio Inc stock outperform Dow Jones indexLong Setup & Verified Momentum Watchlists - moha.gov.vn
Can INmune Bio Inc. stock withstand economic slowdownEarnings Revision Updates & Breakout Portfolio Performance - ulpravda.ru
INmune Bio Inc Stock Analysis and ForecastTechnology Stock Trends & Exceptional Capital Growth - earlytimes.in
How INmune Bio Inc. stock performs in high volatility marketsEnergy Sector Updates & Small Investment Capital Tips - bollywoodhelpline.com
Inmune Bio Amends April 2024 Investor Warrants - TipRanks
INMB (INmune Bio) EV-to-OCF : -0.76 (As of Dec. 22, 2025) - GuruFocus
INMB (INmune Bio) EV-to-FCF : -0.75 (As of Dec. 22, 2025) - GuruFocus
Aug Wrap: How interest rate cuts could boost INmune Bio Inc stockQuarterly Earnings Summary & Real-Time Buy Signal Notifications - moha.gov.vn
Winners Losers: What is the fair value of INmune Bio Inc stock nowChart Signals & Accurate Trade Setup Notifications - moha.gov.vn
Gains Report: Is INmune Bio Inc stock a top pick in earnings seasonQuarterly Portfolio Review & Weekly Watchlist of Top Performers - moha.gov.vn
Why analysts upgrade INmune Bio Inc. stockMarket Performance Recap & Expert Curated Trade Ideas - Улправда
INmune Bio Establishes $65 Million At-The-Market Offering - The Globe and Mail
Will INmune Bio Inc. stock attract more institutional investorsLayoff News & Smart Money Movement Alerts - Улправда
Aug Highlights: Is INmune Bio Inc. stock attractive for long term wealth buildingWeekly Trading Summary & Verified Technical Trade Signals - Улправда
INMune Bio establishes $65 million at-the-market offering - MSN
Is INmune Bio Inc. stock a good choice for value investorsRecession Risk & Real-Time Buy Zone Alerts - Улправда
INmune Bio Signs Sales Agreement With A.G.P./Alliance Global Partners - TradingView — Track All Markets
Is INmune Bio Inc. stock resilient to inflation2025 Fundamental Recap & Community Verified Trade Alerts - DonanımHaber
INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial - MSN
Is INmune Bio Inc. stock a top pick in earnings season2025 Volatility Report & Consistent Income Trade Ideas - DonanımHaber
INmune Bio Shares Collapse After Mixed Results from Alzheimer’s Drug Trial - MSN
INmune Bio Earnings Notes - Trefis
INmune Bio (NASDAQ:INMB) Rating Increased to Hold at Wall Street Zen - MarketBeat
Aug Closing: Is INmune Bio Inc stock resilient to inflationTrade Risk Report & Expert Verified Movement Alerts - moha.gov.vn
Praetorian PR LLC Sells 863,000 Shares of INmune Bio, Inc. $INMB - MarketBeat
Inmune Bio to Host Q3 Results Conference Call - MSN
Inmune Bio Reports Q3 2025 Financial Results - MSN
Inmune Bio Ends Sales Agreement with RBC and BTIG - TipRanks
Can INmune Bio Stock Hold Up When Markets Turn? - Trefis
Can INmune Bio (NASDAQ:INMB) Afford To Invest In Growth? - Sahm
Would You Still Hold INmune Bio Stock If It Fell 30%? - Trefis
Inmune Bio Unveils Promising Alzheimer’s Trial Data - MSN
Insider Sell: Why INmune Bio Inc stock could see breakout soonJuly 2025 Momentum & AI Enhanced Market Trend Forecasts - moha.gov.vn
Retail Trends: Can INmune Bio Inc stock beat analyst upgradesMarket Activity Report & Verified Chart Pattern Signals - BỘ NỘI VỤ
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as Inmune Bio's CORDStrom?? Platform - marketscreener.com
INMB: INmune Bio Highlights Future Potential of MSC Therapies - GuruFocus
INmune Bio, Inc. Announces Publication on Future Applications of Mesenchymal Stromal Cell Therapies - Quiver Quantitative
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform - The Manila Times
Inmune Bio Updates Executive Employment Agreements - TipRanks
INMB SEC FilingsInmune Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Could INmune Bio Unlock Value With Upcoming Regulatory Catalysts And Clinical Readouts? - RTTNews
Why INmune Bio Inc. stock could see breakout soonWeekly Loss Report & Daily Momentum Trading Reports - Newser
Can INmune Bio Inc. stock beat analyst upgradesStock Surge & Free Technical Confirmation Trade Alerts - Newser
Can INmune Bio Stock Recover If Markets Fall? - Trefis
Inmune Bio Inc Azioni (INMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):